577 filings
Page 2 of 29
8-K
s8sefh2zroqf kc0
20 Dec 22
Regulation FD Disclosure
7:05am
CT ORDER
i4i95gy7w
29 Nov 22
Confidential treatment order
12:25pm
8-K
y749bbdo
10 Nov 22
Altimmune Announces Third Quarter 2022 Financial Results and Provides a Business Update
7:06am
8-K
bz4trur 47fw8i57ve0
29 Sep 22
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
xj3iakgyhl
14 Sep 22
Regulation FD Disclosure
7:13am
8-K
x82fcqh34u154j1
11 Aug 22
Altimmune Announces Second Quarter 2022 Financial Results and Provides a Business Update
7:09am
8-K
y4opdah082775
12 May 22
Altimmune Announces First Quarter 2022 Financial Results and Provides a Corporate Update
7:07am
S-8
3fnwh
15 Mar 22
Registration of securities for employees
4:26pm
8-K
nppy5v1j0v0c5z l4
15 Mar 22
Altimmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
7:07am
8-K
j848zxzi4x54hds ed
17 Dec 21
Termination of a Material Definitive Agreement
5:15pm
8-K
5czkxe
13 Dec 21
Altimmune Appoints Richard Eisenstadt as Chief Financial Officer
6:30am
8-K
57et9r
9 Nov 21
Altimmune Announces Third Quarter 2021 Financial Results
4:08pm
8-K
q2roy
28 Sep 21
Altimmune Announces Positive Results From 12-week Phase 1 Clinical Trial of
7:10am